Search Results 131-140 of 18401 for crohn's disease

1. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment.

2. A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease - Mayo Clinic

   Clinical Trials · A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease · More about research at Mayo Clinic · Mayo Clinic Footer.

3. A Study to Evaluate the Effectiveness and Safety of TD-1473 in Crohn's Disease - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease ...

4. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

5. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

   ... Crohn's Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population ... Participant eligibility includes age, gender, type and stage of disease, and ...

6. Mayo Clinic Radio: Crohn's disease / pituitary gland / infant sleep recommendations

   Symptoms can include diarrhea, abdominal pain and weight loss. On the next Mayo Clinic Radio program, learn about treating Crohn's disease from Mayo Clinic ...

7. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

   Approved in 1998 for use in treating Crohn's disease and subsequently in ... inflammatory bowel disease (IBD) symptoms. Unfortunately, about a third of ...

8. Bowel Disease Increases Risk for Stroke and Heart Attack - Mayo Clinic News Network

   More than 1.5 million Americans have Crohn's disease or ulcerative colitis, the most common forms of inflammatory bowel disease. Both conditions inflame the ...

9. Crohn's disease - Doctors and departments - Mayo Clinic

   Departments that treat this condition · Colon and Rectal Surgery · Gastroenterology and Hepatology · Inflammatory Bowel Disease Clinic · Laboratory Medicine and ...

10. A Study to Analyze AVB-114 to Treat Complex Crohn’s Perianal Fistulas in Subjects with Quiescent Rectal Disease - Mayo Clinic

    ... Crohn's Disease. It also aims to assess clinical and radiologic components of fistula remission, safety of treatment, disease activity, patient Quality of ...